HAE Haemonetics Corporation Common Stock
$107,27
Fiyat · Ağu 21, 2026
Temel veriler itibarıyla Ağu 6, 2026
52 Haftlık Aralık
$47–$110
96% of range
Analist Derecelendirmesi
BUY
15 analysts
Fiyat Hedefi
$104
P/E (TTM)
52.3
ROE
11.8%
Net Kâr Marjı
7.3%
Haemonetics Corporation Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Devamını oku
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
History
The company was founded in 1971. Haemonetics started out producing the containers and bags required for blood collection. The Latham Bowl was a disposable container that could automate the separation of blood by centrifugation. Through the 90's, the company added additional product lines and technologies. The company opened a manufacturing facility in Holbrook, Massachusetts in 1988.
In 1995 the company purchased the Intravenous Solutions manufacturing facility in Union, South Carolina.
Additional acquisitions grew the company and expanded its services. In the following years the company branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. These acquisitions included Edmonton-based Fifth Dimension (5D) Information Systems to gain entry into the blood and plasma software industry. Further acquisitions include Chicago-based Arryx in July 2006, Information Data Management, Inc. in January 2007, the acquisition of a division of Haemoscope in 2007, the acquisition of Infonale in July 2007, and, in 2009, Chico, California-based Altivation and Tucson, Arizona-based Sebra.
On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions. The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.
Further acquisitions included the April 2009 acquisition of Neoteric Technology Ltd and the April 2010 acquisition of California-based Global Med Technologies, Inc. Haemonetics acquired the Pall Corporation's transfusion medicine business on August 1, 2012 for ~$550 million.
In April 2024, it was announced Haemonetics had completed its acquisition of the Chicago-headquartered medical device temperature regulation manufacturer, Attune Medical for $160 million.
Product categories
Haemonetics products can be considered as belonging to two broad categories. Donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit); and products that are marketed to the surgical suite for blood loss management for patients. These products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.
Hemostasis
TEG 5000
Kaolin TEG
Kaolin TEG with Heparinase
RapidTEG
TEG Functional Fibrinogen
TEG PlateletMapping
TEG 6S
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
HAE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$107.27
Piyasa Değeri
$4.85B
P/E (TTM)
52.3
EPS (TTM)
$2.05
Gelir (TTM)
$1.33B
Temettü Verimi
—
ROE
11.8%
D/E Borç/Özsermaye
1.5
52 Haftlık Aralık
$47 – $110
HAE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$1.33B
2017-04-01
→
2026-03-28
Hisse Başına Kâr
$2.05
2017-04-01
→
2026-03-28
Serbest Nakit Akışı
$260M
2017-04-01
→
2026-03-28
Marjlar
7.3%
2017-04-01
→
2026-03-28
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
HAE
Akran Ortalaması
P/E (TTM)
52.3
39.4
P/S (TTM) (F/S (TTM))
3.6
2.1
P/B (F/D)
6.1
3.3
EV / EBITDA
37.2
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
18.6
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
HAE
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
59.0%
58.7%
Operating Margin (Faaliyet Kâr Marjı)
11.8%
—
Net Profit Margin (Net Kâr Marjı)
7.3%
-11.8%
ROA
4.0%
-6.3%
ROE
11.8%
-13.4%
ROIC
5.9%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
HAE
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
1.5
37.4
Current Ratio (Cari Oran)
3.0
2.4
Quick Ratio (Cari Oran)
1.6
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
HAE
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-2.0%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
4.5%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
8.9%
—
EPS YoY (EPS YB)
-38.1%
—
Net Income YoY (Net Gelir Yıllık Bazda)
-42.0%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
HAE
Akran Ortalaması
HAE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
15 analist
- Güçlü Al 5 33,3%
- Al 6 40,0%
- Tut 4 26,7%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
10 analist · 2026-08-20
Medyan
$104.50
Şimdi
$107.27
Düşük
$86.00
Yüksek
$120.00
Medyan hedef
$104.50
-2,6%
Ortalama hedef
$104.10
-3,0%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.06%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2027 | $1.14 | $1.09 | 0.05% |
| 30 Haziran 2026 | $1.14 | $1.09 | 0.05% |
| 31 Mart 2026 | $1.29 | $1.28 | 0.01% |
| 31 Aralık 2025 | $1.31 | $1.26 | 0.05% |
| 30 Eylül 2025 | $1.27 | $1.12 | 0.15% |
| 30 Haziran 2025 | $1.10 | $1.03 | 0.07% |
| 31 Mart 2025 | $1.24 | $1.23 | 0.01% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Cost of Revenue | $546M | $612M | $618M | $554M | $488M | $473M | $504M | $550M | $492M | $508M | $503M | $476M | |
| Gross Profit | $788M | $749M | $692M | $615M | $506M | $398M | $485M | $418M | $412M | $378M | $406M | $434M | |
| R&D Expense | $60M | $63M | $54M | $50M | $47M | $33M | $31M | $36M | $39M | $38M | $45M | $54M | |
| SG&A Expense | $442M | $437M | $430M | $377M | $340M | $275M | $282M | $273M | $317M | $302M | $317M | $337M | |
| Operating Expenses | $631M | $527M | $527M | $459M | $425M | $308M | $381M | $334M | $356M | $398M | $450M | $394M | |
| Operating Income | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M | |
| Other Non-op | $-29M | $-10M | $-13M | $-15M | $-17M | $-17M | $-16M | $-10M | $-5M | $-8M | $-9M | $-9M | |
| Pretax Income | $128M | $212M | $152M | $141M | $64M | $73M | $87M | $74M | $60M | $-27M | $-53M | $31M | |
| Income Tax | $31M | $44M | $34M | $26M | $20M | $-7M | $11M | $19M | $14M | $-1M | $2M | $14M | |
| Net Income | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| EPS (Basic) | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 | $1.57 | $1.51 | $1.07 | $0.86 | $-0.51 | $-1.09 | $0.33 | |
| EPS (Diluted) | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | $-0.51 | $-1.09 | $0.32 | |
| Shares (Basic) | 47,179,000 | 50,330,000 | 50,706,000 | 50,783,000 | 51,047,000 | 50,688,000 | 50,692,000 | 51,533,000 | 52,755,000 | 51,524,000 | 50,910,000 | 51,533,000 | |
| Shares (Diluted) | 47,354,000 | 50,730,000 | 51,397,000 | 51,420,000 | 51,353,000 | 51,292,000 | 51,815,000 | 52,942,000 | 53,501,000 | 51,524,000 | 50,910,000 | 52,089,000 | |
| EBITDA | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M |
Bilanço 25
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $245M | $307M | $179M | $284M | $259M | $192M | $137M | $169M | $180M | $140M | $115M | $161M | |
| Receivables | $217M | $203M | $207M | $179M | $159M | $128M | $165M | $185M | $151M | $153M | $157M | $146M | |
| Inventory | $306M | $365M | $317M | $259M | $293M | $323M | $270M | $194M | $161M | $177M | $187M | $211M | |
| Prepaid Expense | $66M | $60M | $66M | $47M | $44M | $51M | $31M | $27M | $29M | $41M | $29M | $40M | |
| Current Assets | $835M | $935M | $769M | $770M | $756M | $694M | $604M | $576M | $521M | $510M | $488M | $558M | |
| PP&E (Net) | $306M | $284M | $311M | $311M | $258M | $218M | $253M | $344M | $332M | $324M | $338M | $322M | |
| PP&E (Gross) | $842M | $837M | $959M | $944M | $869M | $817M | $832M | $933M | $873M | $807M | $786M | $732M | |
| Accum. Depreciation | $536M | $553M | $648M | $633M | $611M | $600M | $579M | $589M | $541M | $484M | $449M | $410M | |
| Goodwill | $656M | $604M | $565M | $466M | $467M | $466M | $211M | $211M | $211M | $211M | $268M | $334M | |
| Intangibles | $448M | $456M | $406M | $276M | $310M | $365M | $133M | $128M | $157M | $178M | $204M | $245M | |
| Other Non-current Assets | $142M | $164M | $136M | $107M | $63M | $71M | $62M | $12M | $12M | $12M | $14M | $11M | |
| Total Assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Accounts Payable | $51M | $67M | $73M | $64M | $58M | $50M | $51M | $63M | $55M | $43M | $40M | $48M | |
| Current Liabilities | $283M | $578M | $300M | $252M | $442M | $253M | $275M | $236M | $385M | $211M | $186M | $189M | |
| Capital Leases | $41M | $50M | $58M | $56M | $56M | $63M | $52M | · | · | · | · | · | |
| Deferred Tax | $38M | $63M | $63M | $36M | $29M | $44M | $11M | $20M | $7M | $12M | $21M | $33M | |
| Other Non-current Liabilities | $59M | $68M | $75M | $75M | $80M | $100M | $89M | $29M | $34M | $22M | $26M | $32M | |
| Long-term Debt | $1.24B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $316M | $408M | $430M | |
| Total Debt | $1.22B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $315M | $408M | $428M | |
| Common Stock | $453.0K | $482.0K | $508.0K | $504.0K | $511.0K | $509.0K | $503.0K | $510.0K | $523.0K | $523.0K | $509.0K | $517.0K | |
| Retained Earnings | $279M | $352M | $360M | $253M | $202M | $158M | $79M | $161M | $267M | $290M | $316M | $420M | |
| AOCI | $-38M | $-55M | $-36M | $-30M | $-26M | $-30M | $-45M | $-30M | $-19M | $-33M | $-35M | $-22M | |
| Stockholders' Equity | $796M | $821M | $960M | $818M | $749M | $732M | $587M | $668M | $752M | $740M | $722M | $826M | |
| Liabilities + Equity | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Shares Outstanding | 45,252,667 | 48,215,899 | 50,787,859 | 50,448,519 | 51,124,240 | 50,868,820 | 50,322,930 | 51,019,918 | 52,342,965 | 52,255,495 | 50,932,348 | 51,670,969 |
Nakit Akışı 16
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $112M | $116M | $97M | $93M | $98M | $84M | $110M | $109M | $89M | $90M | $90M | $86M | |
| Stock-based Comp | $34M | $30M | $28M | $26M | $24M | $26M | $20M | $17M | $13M | $9M | $7M | $14M | |
| Deferred Tax | $-26M | $-6M | $-11M | $6M | $5M | $-21M | $-7M | $13M | $-6M | $-7M | $-1M | $4M | |
| Amort. of Intangibles | $50M | $56M | $41M | $42M | $57M | $41M | $34M | $25M | $32M | $37M | $59M | $34M | |
| Restructuring | $3M | $14M | $14M | $657.0K | $4M | $1M | $4M | $395.0K | $31M | $22M | $23M | $37M | |
| Operating Cash Flow | $293M | $182M | $182M | $273M | $172M | $109M | $158M | $159M | $220M | $160M | $122M | $127M | |
| CapEx | $33M | $39M | $38M | $191M | $97M | $37M | $49M | $119M | $75M | $76M | $102M | $122M | |
| Investing Cash Flow | $-180M | $-162M | $-322M | $-144M | $-86M | $-425M | $-57M | $-116M | $-63M | $-73M | $-105M | $-122M | |
| Debt Issued | · | · | · | · | · | · | $0 | $348M | $0 | $0 | · | $0 | |
| Net Debt Issued | · | $-5M | $-12M | $-10M | $-18M | $-22M | $-13M | $81M | $-62M | $-43M | $-21M | $-9M | |
| Stock Repurchased | $175M | $225M | $0 | $75M | $0 | $0 | $175M | $160M | $100M | $0 | $61M | $39M | |
| Net Stock Activity | $-175M | $-225M | $0 | $-75M | $0 | $0 | $-175M | $-160M | $-100M | $0 | $-61M | $-39M | |
| Financing Cash Flow | $-178M | $109M | $38M | $-100M | $-16M | $367M | $-131M | $-51M | $-121M | $-60M | $-63M | $-33M | |
| Net Change in Cash | $-61M | $128M | $-106M | $25M | $67M | $55M | $-32M | $-11M | $41M | $24M | $-46M | $-32M | |
| Taxes Paid | $61M | · | · | · | · | $12M | $12M | $8M | $9M | $7M | $8M | $11M | |
| Free Cash Flow | $260M | $142M | $115M | $163M | $76M | $72M | $109M | $40M | $146M | $84M | $19M | $5M |
Kârlılık 8
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% | 45.7% | 49.0% | 43.1% | 45.6% | 42.7% | 44.7% | 47.7% | |
| Operating Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| Net Margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% | 9.1% | 7.7% | 5.7% | 5.0% | -3.0% | -6.1% | 1.9% | |
| Pretax Margin | 9.6% | 15.6% | 11.6% | 12.1% | 6.4% | 8.4% | 8.8% | 7.6% | 6.6% | -3.1% | -5.9% | 3.4% | |
| EBITDA Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| ROA | 4.0% | 7.2% | 5.7% | 6.1% | 2.4% | 5.1% | 6.0% | 4.4% | 3.7% | -2.1% | -4.0% | 1.1% | |
| ROE | 11.8% | 19.4% | 12.3% | 14.5% | 5.9% | 11.0% | 13.2% | 8.7% | 6.1% | -3.6% | -7.2% | 2.0% | |
| ROIC | 5.9% | 8.6% | 7.2% | 8.0% | 3.6% | 6.8% | 9.4% | 6.1% | 4.3% | -1.8% | -4.0% | 1.8% |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 | 2.7 | 2.2 | 2.4 | 1.4 | 2.4 | 2.6 | 3.0 | |
| Quick Ratio | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 | 1.3 | 1.1 | 1.5 | 0.9 | 1.4 | 1.5 | 1.6 | |
| Debt / Equity | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 | 1.0 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.5 | |
| LT Debt / Equity | 1.5 | 1.1 | 0.8 | 0.9 | 0.7 | 0.9 | 0.5 | 0.5 | 0.1 | 0.3 | 0.5 | 0.5 |
Verimlilik 3
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.8 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | |
| Inventory Turnover | 1.6 | 1.8 | 2.1 | 2.0 | 1.6 | 1.6 | 2.2 | 3.1 | 2.9 | 2.8 | 2.5 | 2.3 | |
| Receivables Turnover | 6.4 | 6.7 | 6.8 | 6.9 | 6.9 | 5.9 | 5.6 | 5.8 | 5.9 | 5.7 | 6.0 | 5.9 |
Büyüme Oranları 9
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.0% | 4.0% | 12.0% | 17.7% | 14.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 11.1% | 14.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -38.1% | 44.5% | 2.2% | 166.7% | -45.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -2.9% | 58.0% | 13.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 5.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -42.0% | 42.6% | 1.9% | 166.1% | -45.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -5.5% | 56.9% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Net Income TTM | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| Market Cap | $2.45B | $3.05B | $4.33B | $4.17B | $3.26B | $5.70B | $5.08B | $4.46B | $3.83B | $2.12B | $1.80B | $2.28B | |
| Enterprise Value | $3.42B | $3.96B | $4.96B | $4.66B | $3.78B | $6.21B | $5.33B | $4.64B | $3.90B | $2.30B | $2.09B | $2.55B | |
| P/E | 26.4 | 19.1 | 37.3 | 36.9 | 76.0 | 72.3 | 68.2 | 84.1 | 86.1 | -79.5 | -32.4 | 138.2 | |
| P/S | 1.8 | 2.2 | 3.3 | 3.6 | 3.3 | 6.5 | 5.1 | 4.6 | 4.2 | 2.4 | 2.0 | 2.5 | |
| P/B | 3.1 | 3.7 | 4.5 | 5.1 | 4.4 | 7.8 | 8.7 | 6.7 | 5.1 | 2.9 | 2.5 | 2.8 | |
| P / Tangible Book | · | · | · | 54.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 8.3 | 16.8 | 23.8 | 15.3 | 18.9 | 52.4 | 32.1 | 28.0 | 17.4 | 13.3 | 14.7 | 18.0 | |
| P / FCF | 9.4 | 21.4 | 37.5 | 25.6 | 43.1 | 79.4 | 46.4 | 110.7 | 26.3 | 25.4 | 92.4 | 460.7 | |
| EV / EBITDA | 21.8 | 17.9 | 30.1 | 29.8 | 46.8 | 69.2 | 51.5 | 55.6 | 69.5 | -118.4 | -47.6 | 62.9 | |
| EV / FCF | 13.1 | 27.8 | 43.0 | 28.6 | 49.9 | 86.6 | 48.7 | 115.2 | 26.8 | 27.5 | 107.4 | 514.6 | |
| EV / Revenue | 2.6 | 2.9 | 3.8 | 4.0 | 3.8 | 7.1 | 5.4 | 4.8 | 4.3 | 2.6 | 2.3 | 2.8 | |
| Earnings Yield | 3.8% | 5.2% | 2.7% | 2.7% | 1.3% | 1.4% | 1.5% | 1.2% | 1.2% | -1.3% | -3.1% | 0.72% |
Gelir Tablosu 16
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $339M | $346M | $339M | $327M | $321M | $331M | $349M | $346M | $336M | $343M | $336M | $318M | $340M | $305M | $297M | |
| Cost of Revenue | $137M | $148M | $137M | $133M | $129M | $138M | $155M | $158M | $161M | $167M | $158M | $148M | $169M | $147M | $140M | |
| Gross Profit | $203M | $198M | $202M | $195M | $192M | $193M | $194M | $187M | $175M | $176M | $178M | $171M | $172M | $159M | $158M | |
| R&D Expense | $16M | $14M | $14M | $15M | $16M | $18M | $16M | $14M | $14M | $16M | $13M | $13M | $16M | $13M | $11M | |
| SG&A Expense | $119M | $121M | $109M | $102M | $111M | $115M | $106M | $107M | $108M | $109M | $112M | $115M | $98M | $95M | $92M | |
| Operating Expenses | $145M | $221M | $135M | $136M | $138M | $122M | $135M | $136M | $135M | $146M | $132M | $135M | $121M | $115M | $111M | |
| Operating Income | $57M | $-23M | $67M | $58M | $54M | $71M | $59M | $52M | $40M | $30M | $46M | $35M | $51M | $43M | $47M | |
| Other Non-op | $-10M | $-5M | $-7M | $-7M | $-9M | $-598.0K | $-9M | $-7M | $7M | $-7M | $-2M | $-2M | $-3M | $-1M | $-6M | |
| Pretax Income | $48M | $-28M | $60M | $51M | $45M | $71M | $50M | $45M | $47M | $23M | $44M | $33M | $48M | $42M | $41M | |
| Income Tax | $15M | $-8M | $15M | $13M | $11M | $13M | $12M | $11M | $8M | $3M | $13M | $8M | $5M | $9M | $8M | |
| Net Income | $33M | $-20M | $45M | $39M | $34M | $58M | $37M | $34M | $38M | $20M | $31M | $25M | $42M | $33M | $33M | |
| EPS (Basic) | $0.73 | $-0.42 | $0.96 | $0.81 | $0.71 | $1.17 | $0.75 | $0.66 | $0.75 | $0.40 | $0.62 | $0.49 | $0.84 | $0.65 | $0.65 | |
| EPS (Diluted) | $0.72 | $-0.41 | $0.95 | $0.81 | $0.70 | $1.17 | $0.74 | $0.66 | $0.74 | $0.40 | $0.61 | $0.48 | $0.84 | $0.64 | $0.64 | |
| Shares (Basic) | 45,361,000 | -95,314,000 | 46,792,000 | 47,590,000 | 48,111,000 | -101,797,000 | 50,286,000 | 50,898,000 | 50,943,000 | 27,000 | 50,768,000 | 50,727,000 | -102,174,000 | 50,509,000 | 50,953,000 | |
| Shares (Diluted) | 45,704,000 | -95,650,000 | 46,987,000 | 47,664,000 | 48,353,000 | -102,713,000 | 50,639,000 | 51,240,000 | 51,564,000 | 3,000 | 51,445,000 | 51,396,000 | -103,165,000 | 51,219,000 | 51,558,000 | |
| EBITDA | $57M | · | $67M | $58M | $54M | · | $59M | $52M | $40M | · | $46M | $35M | · | $43M | $47M |
Bilanço 25
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $223M | $245M | $363M | $296M | $293M | $307M | $321M | $299M | $344M | $179M | $194M | $351M | · | $224M | $241M | |
| Receivables | $216M | $217M | $196M | $207M | $201M | $203M | $212M | $214M | $201M | $207M | $212M | $174M | · | $181M | $172M | |
| Inventory | $307M | $306M | $321M | $336M | $361M | $365M | $360M | $382M | $374M | $317M | $304M | $286M | · | $256M | $255M | |
| Prepaid Expense | $65M | $66M | $63M | $60M | $59M | $60M | $113M | $61M | $59M | $66M | $55M | $55M | · | $45M | $48M | |
| Current Assets | $811M | $835M | $944M | $900M | $913M | $935M | $1.01B | $956M | $979M | $769M | $765M | $866M | · | $706M | $716M | |
| PP&E (Net) | $304M | $306M | $297M | $292M | $287M | $284M | $286M | $300M | $302M | $311M | $319M | $308M | · | $313M | $308M | |
| PP&E (Gross) | $854M | $842M | $837M | $815M | $795M | $837M | $867M | $939M | $949M | $959M | $979M | $950M | · | · | · | |
| Accum. Depreciation | $550M | $536M | $540M | $523M | $508M | $553M | $581M | $639M | $647M | $648M | $661M | $642M | · | · | · | |
| Goodwill | $657M | $656M | $607M | $606M | $607M | $604M | $605M | $616M | $613M | $565M | $555M | $465M | $466M | $466M | $465M | |
| Intangibles | $435M | $448M | $420M | $428M | $451M | $456M | $466M | $488M | $495M | $406M | $429M | $251M | · | $284M | $293M | |
| Other Non-current Assets | $150M | $142M | $216M | $208M | $196M | $164M | $160M | $156M | $142M | $136M | $127M | $117M | · | $103M | $80M | |
| Total Assets | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Accounts Payable | $56M | $51M | $49M | $62M | $46M | $67M | $63M | $69M | $77M | $73M | $57M | $80M | · | $64M | $61M | |
| Current Liabilities | $263M | $283M | $540M | $548M | $531M | $578M | $253M | $274M | $260M | $300M | $262M | $264M | · | $227M | $262M | |
| Capital Leases | · | $41M | · | · | · | $50M | · | · | · | $58M | · | · | · | · | · | |
| Deferred Tax | $39M | $38M | $56M | $58M | $59M | $63M | $61M | $63M | $65M | $63M | $62M | $35M | · | $40M | $36M | |
| Other Non-current Liabilities | $57M | $59M | $64M | $66M | $68M | $68M | $90M | $90M | $92M | $75M | $76M | $70M | · | $78M | $78M | |
| Long-term Debt | $1.19B | $1.24B | $1.22B | $1.22B | $1.22B | $1.25B | $1.22B | $1.22B | $1.22B | $808M | $871M | $762M | · | $767M | $818M | |
| Total Debt | $1.17B | · | $1.22B | $1.22B | $1.22B | · | $1.22B | $1.22B | $1.22B | · | $871M | $762M | · | $767M | $818M | |
| Common Stock | $455.0K | $453.0K | $468.0K | $467.0K | $482.0K | $482.0K | $502.0K | $504.0K | $512.0K | $508.0K | $508.0K | $507.0K | · | $504.0K | $506.0K | |
| Retained Earnings | $312M | $279M | $381M | $336M | $356M | $352M | $392M | $369M | $387M | $360M | $340M | $309M | · | $224M | $204M | |
| AOCI | $-42M | $-38M | $-35M | $-41M | $-36M | $-55M | $-56M | $-35M | $-43M | $-36M | $-24M | $-33M | · | $-36M | $-40M | |
| Stockholders' Equity | $837M | $796M | $911M | $849M | $882M | $821M | $907M | $879M | $905M | $960M | $943M | $894M | $818M | $776M | $729M | |
| Liabilities + Equity | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Shares Outstanding | 45,471,313 | 45,252,667 | 46,829,249 | 46,747,381 | 48,158,723 | 48,215,899 | 50,235,051 | 50,381,127 | 51,152,886 | 50,787,859 | 50,785,040 | 50,740,389 | · | 50,444,470 | 50,605,499 |
Nakit Akışı 13
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $27M | $27M | $27M | $28M | $29M | $28M | $29M | $29M | $29M | $28M | $24M | · | $24M | $24M | · | |
| Stock-based Comp | $9M | $9M | $8M | $8M | $9M | $7M | $8M | $7M | $8M | $7M | $7M | · | $7M | $7M | · | |
| Deferred Tax | $668.0K | $-20M | $-2M | $-725.0K | $-3M | $3M | $-2M | $-2M | $-4M | $-6M | $-3M | · | · | · | · | |
| Amort. of Intangibles | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $13M | $9M | $9M | $15M | $10M | $11M | |
| Restructuring | $2M | $196.0K | $1M | $204.0K | $1M | $984.0K | $4M | $5M | $5M | $6M | $8M | $86.0K | $701.0K | $44.0K | $165.0K | |
| Operating Cash Flow | $52M | $71M | $94M | $111M | $17M | $117M | $44M | $49M | $-27M | $64M | $-540.0K | · | $80M | $64M | · | |
| CapEx | $8M | $18M | $6M | $5M | $4M | $16M | $9M | $9M | $6M | $7M | $-3M | · | $93M | $17M | · | |
| Investing Cash Flow | $-22M | $-87M | $-29M | $-30M | $-33M | $18M | $-17M | $-23M | $-139M | $-13M | $-269M | · | $-18M | $-36M | · | |
| Net Debt Issued | $-2M | · | · | · | $-2M | · | · | · | $-2M | · | · | · | · | · | · | |
| Stock Repurchased | · | $100M | $0 | · | · | $150M | $0 | · | · | $0 | $0 | · | $0 | $0 | · | |
| Financing Cash Flow | $-52M | $-101M | $2M | $-77M | $-2M | $-151M | $1M | $-75M | $334M | $-64M | $109M | · | $-2M | $-50M | · | |
| Net Change in Cash | $-22M | $-118M | $67M | $4M | $-14M | $-14M | $22M | $-45M | $166M | $-15M | $-157M | · | $60M | $-17M | · | |
| Free Cash Flow | $44M | · | · | · | $14M | · | · | · | $-33M | · | · | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.8% | · | 59.7% | 59.5% | 59.8% | · | 55.5% | 54.2% | 52.0% | · | 52.9% | 53.6% | · | 52.0% | 53.1% | |
| Operating Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| Net Margin | 9.7% | · | 13.2% | 11.8% | 10.6% | · | 10.8% | 9.8% | 11.4% | · | 9.3% | 7.8% | · | 10.8% | 11.2% | |
| Pretax Margin | 14.0% | · | 17.7% | 15.7% | 14.1% | · | 14.3% | 12.9% | 13.9% | · | 13.1% | 10.3% | · | 13.8% | 13.8% | |
| EBITDA Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| ROA | 1.4% | · | 1.8% | 1.6% | 1.4% | · | 1.6% | 1.5% | 1.7% | · | 1.5% | 1.3% | · | 1.8% | 1.8% | |
| ROE | 3.8% | · | 4.9% | 4.5% | 3.8% | · | 4.0% | 3.8% | 4.3% | · | 3.6% | 3.1% | · | 4.4% | 4.7% | |
| ROIC | 2.0% | · | 2.4% | 2.1% | 1.9% | · | 2.1% | 1.9% | 1.5% | · | 1.8% | 1.6% | · | 2.2% | 2.4% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | 1.7 | 1.6 | 1.7 | · | 4.0 | 3.5 | 3.8 | · | 2.9 | 3.3 | · | 3.1 | 2.7 | |
| Quick Ratio | 1.7 | · | 1.0 | 0.9 | 0.9 | · | 2.1 | 1.9 | 2.1 | · | 1.5 | 2.0 | · | 1.8 | 1.6 | |
| Debt / Equity | 1.4 | · | 1.3 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 0.9 | 0.9 | · | 1.0 | 1.1 | |
| LT Debt / Equity | 1.4 | · | 1.0 | 1.1 | 1.0 | · | 1.3 | 1.4 | 1.3 | · | 0.9 | 0.8 | · | 1.0 | 1.0 |
Verimlilik 3
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.2 | 0.2 | · | 0.2 | 0.2 | |
| Inventory Turnover | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| Receivables Turnover | 1.6 | · | 1.7 | 1.6 | 1.6 | · | 1.6 | 1.8 | 1.8 | · | 1.7 | 1.8 | · | 1.8 | 1.9 |
Değerleme (TTM) 14
| Metrik | Eğilim | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | · | $1.34B | $1.34B | $1.35B | · | $1.37B | $1.34B | $1.30B | · | $1.27B | $1.23B | · | · | · | |
| Net Income TTM | $150M | · | $155M | $144M | $144M | · | $141M | $128M | $136M | · | $130M | $132M | · | · | · | |
| Market Cap | $3.51B | · | $3.76B | $2.25B | $3.55B | · | $3.90B | $4.02B | $4.23B | · | $4.34B | $4.55B | · | $3.97B | $3.75B | |
| Enterprise Value | $4.47B | · | $4.62B | $3.18B | $4.49B | · | $4.80B | $4.95B | $5.11B | · | $5.02B | $4.96B | · | $4.51B | $4.32B | |
| P/E | 24.3 | · | 25.1 | 16.6 | 26.0 | · | 28.2 | 32.0 | 31.5 | · | 33.8 | 35.0 | · | · | · | |
| P/S | 2.6 | · | 2.8 | 1.7 | 2.6 | · | 2.9 | 3.0 | 3.3 | · | 3.4 | 3.7 | · | · | · | |
| P/B | 4.2 | · | 4.1 | 2.7 | 4.0 | · | 4.3 | 4.6 | 4.7 | · | 4.6 | 5.1 | · | 5.1 | 5.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 25.6 | · | 155.7 | · | |
| P / Cash Flow | 67.2 | · | · | · | 204.3 | · | · | · | -154.3 | · | · | · | · | · | · | |
| P / FCF | 79.1 | · | · | · | 260.5 | · | · | · | -127.9 | · | · | · | · | · | · | |
| EV / EBITDA | 77.7 | · | 68.6 | 54.4 | 83.3 | · | 81.3 | 95.7 | 128.6 | · | 109.2 | 140.4 | · | 104.2 | 92.5 | |
| EV / FCF | 100.5 | · | · | · | 328.9 | · | · | · | -154.5 | · | · | · | · | · | · | |
| EV / Revenue | 3.4 | · | 3.5 | 2.4 | 3.3 | · | 3.5 | 3.7 | 3.9 | · | 3.9 | 4.0 | · | · | · | |
| Earnings Yield | 4.1% | · | 4.0% | 6.0% | 3.9% | · | 3.5% | 3.1% | 3.2% | · | 3.0% | 2.9% | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Gelir | $1.33B | $1.36B | $1.31B | $1.17B | $993M |
| Brüt Kâr Marjı % | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% |
| Faaliyet Kâr Marjı % | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% |
| Net Gelir | $97M | $168M | $118M | $115M | $43M |
| Seyreltilmiş Hisse Başı Kâr | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
Bilanço
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 |
| Cari Oran | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 |
| Cari Oran | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 |
Nakit Akışı
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $260M | $142M | $115M | $163M | $76M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 363 dosya · $2.6B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 56 (-3 önceki Ç'ye göre) | 43 (-12 önceki Ç'ye göre) | 111 (-2 önceki Ç'ye göre) | 114 (-1 önceki Ç'ye göre) | +1.2M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $349.945.961 | 4.366.138 | 13,44% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $308.172.249 | 4.108.761 | 11,84% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $190.979.550 | 2.546.394 | 7,34% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $154.468.350 | 2.059.578 | 5,93% | Hisse senetleri |
| STATE STREET CORP | $136.363.950 | 1.818.186 | 5,24% | Hisse senetleri |
| CITADEL ADVISORS LLC | $113.259.000 | 1.510.120 | 4,35% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $109.143.975 | 1.455.253 | 4,19% | Hisse senetleri |
| River Road Asset Management, LLC | $96.420.150 | 1.285.602 | 3,70% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $86.651.325 | 1.155.351 | 3,33% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $79.315.930 | 1.057.321 | 3,05% | Hisse senetleri |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $62.319.375 | 830.925 | 2,39% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $52.644.150 | 701.922 | 2,02% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $44.356.725 | 591.423 | 1,70% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $42.780.975 | 570.413 | 1,64% | Hisse senetleri |
| Holocene Advisors, LP | $41.264.625 | 550.195 | 1,58% | Hisse senetleri |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $37.034.909 | 493.796 | 1,42% | Hisse senetleri |
| North Peak Capital Management, LLC | $25.730.775 | 343.077 | 0,99% | Hisse senetleri |
| LONDON CO OF VIRGINIA | $25.543.299 | 340.574 | 0,98% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $25.282.575 | 337.101 | 0,97% | Hisse senetleri |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $24.905.625 | 332.075 | 0,96% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $24.779.850 | 330.398 | 0,95% | Hisse senetleri |
| Boston Trust Walden Corp | $24.170.475 | 322.273 | 0,93% | Hisse senetleri |
| Aristotle Capital Boston, LLC | $21.721.809 | 289.624 | 0,83% | Hisse senetleri |
| MIZUHO MARKETS AMERICAS LLC | $21.166.050 | 282.214 | 0,81% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $20.122.875 | 268.305 | 0,77% | Hisse senetleri |
| Invenomic Capital Management LP | $16.216.275 | 216.217 | 0,62% | Hisse senetleri |
| FMR LLC | $15.638.325 | 208.511 | 0,60% | Hisse senetleri |
| HEARTLAND ADVISORS INC | $15.000.000 | 200.000 | 0,58% | Hisse senetleri |
| GLENMEDE TRUST CO NA | $14.454.000 | 192.720 | 0,56% | Hisse senetleri |
| MORGAN STANLEY | $13.073.475 | 174.313 | 0,50% | Hisse senetleri |
| Longaeva Partners L.P. | $12.286.650 | 163.822 | 0,47% | Hisse senetleri |
| RHUMBLINE ADVISERS | $10.812.225 | 144.163 | 0,42% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $10.613.250 | 141.510 | 0,41% | Hisse senetleri |
| Balyasny Asset Management L.P. | $10.123.575 | 134.981 | 0,39% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $9.750.000 | 130.000 | 0,37% | Hisse senetleri |
| Point72 Asset Management, L.P. | $8.192.700 | 109.236 | 0,31% | Hisse senetleri |
| Verition Fund Management LLC | $7.913.100 | 105.508 | 0,30% | Hisse senetleri |
| ARIEL INVESTMENTS, LLC | $7.569.975 | 100.933 | 0,29% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $7.500.000 | 100.000 | 0,29% | Alım opsiyonu |
| KESTREL INVESTMENT MANAGEMENT CORP | $7.305.000 | 97.400 | 0,28% | Hisse senetleri |
| Divisadero Street Capital Management, LP | $7.234.425 | 96.459 | 0,28% | Hisse senetleri |
| Swiss National Bank | $6.997.500 | 93.300 | 0,27% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $6.750.000 | 90.000 | 0,26% | Alım opsiyonu |
| GOLDMAN SACHS GROUP INC | $6.750.000 | 90.000 | 0,26% | Satım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.510.000 | 86.800 | 0,25% | Alım opsiyonu |
| Squarepoint Ops LLC | $6.459.300 | 86.124 | 0,25% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $6.215.025 | 82.867 | 0,24% | Hisse senetleri |
| Quantinno Capital Management LP | $5.477.550 | 73.034 | 0,21% | Hisse senetleri |
| ROYCE & ASSOCIATES LP | $5.360.625 | 71.475 | 0,21% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $5.358.525 | 71.447 | 0,21% | Hisse senetleri |
| JUPITER ASSET MANAGEMENT LTD | $5.229.300 | 69.724 | 0,20% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $5.166.634 | 91.672 | 0,20% | Hisse senetleri |
| SEGALL BRYANT & HAMILL, LLC | $5.106.900 | 68.092 | 0,20% | Hisse senetleri |
| AMERICAN CAPITAL MANAGEMENT INC | $5.018.625 | 66.915 | 0,19% | Hisse senetleri |
| ISTHMUS PARTNERS, LLC | $4.946.325 | 65.951 | 0,19% | Hisse senetleri |
| Corient Private Wealth LP | $4.851.975 | 64.693 | 0,19% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $4.751.850 | 63.358 | 0,18% | Hisse senetleri |
| DEAN INVESTMENT ASSOCIATES, LLC | $4.649.175 | 61.989 | 0,18% | Hisse senetleri |
| PEREGRINE CAPITAL MANAGEMENT LLC | $4.497.450 | 59.966 | 0,17% | Hisse senetleri |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4.484.325 | 59.791 | 0,17% | Hisse senetleri |
| Bridgewater Associates, LP | $4.479.975 | 59.733 | 0,17% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $4.181.475 | 55.753 | 0,16% | Hisse senetleri |
| Trexquant Investment LP | $3.946.425 | 52.619 | 0,15% | Hisse senetleri |
| Aequim Alternative Investments LP | $3.840.000 | 51.200 | 0,15% | Hisse senetleri |
| RICE HALL JAMES & ASSOCIATES, LLC | $3.827.850 | 51.038 | 0,15% | Hisse senetleri |
| JANE STREET GROUP, LLC | $3.682.500 | 49.100 | 0,14% | Alım opsiyonu |
| MetLife Investment Management, LLC | $3.681.075 | 49.081 | 0,14% | Hisse senetleri |
| BlackRock, Inc. | $3.618.975 | 48.253 | 0,14% | Hisse senetleri |
| Retirement Systems of Alabama | $3.604.875 | 48.065 | 0,14% | Hisse senetleri |
| Riverwater Partners LLC | $3.573.375 | 47.645 | 0,14% | Hisse senetleri |
| Skylands Capital, LLC | $3.571.875 | 47.625 | 0,14% | Hisse senetleri |
| FIFTH THIRD BANCORP | $3.561.472 | 47.486 | 0,14% | Hisse senetleri |
| ALGERT GLOBAL LLC | $3.522.750 | 46.970 | 0,14% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.441.750 | 45.890 | 0,13% | Hisse senetleri |
| Qube Research & Technologies Ltd | $3.425.475 | 45.673 | 0,13% | Hisse senetleri |
| Dean Capital Management | $3.372.600 | 44.968 | 0,13% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $3.351.375 | 44.685 | 0,13% | Hisse senetleri |
| EASTERLY INVESTMENT PARTNERS LLC | $3.248.025 | 43.307 | 0,12% | Hisse senetleri |
| Phocas Financial Corp. | $3.227.250 | 43.030 | 0,12% | Hisse senetleri |
| ZB,N.A. | $3.200.968 | 40.996 | 0,12% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3.190.200 | 42.536 | 0,12% | Hisse senetleri |
| CONNORS INVESTOR SERVICES INC | $3.150.000 | 42.000 | 0,12% | Hisse senetleri |
| Expect Equity LLC | $3.076.950 | 41.026 | 0,12% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.964.874 | 52.606 | 0,11% | Hisse senetleri |
| BEACON INVESTMENT ADVISORS LLC | $2.783.648 | 37.115 | 0,11% | Hisse senetleri |
| Campbell & CO Investment Adviser LLC | $2.763.300 | 36.844 | 0,11% | Hisse senetleri |
| Assenagon Asset Management S.A. | $2.633.175 | 35.109 | 0,10% | Hisse senetleri |
| BARCLAYS PLC | $2.448.300 | 32.644 | 0,09% | Hisse senetleri |
| MARSHALL WACE, LLP | $2.286.975 | 30.493 | 0,09% | Hisse senetleri |
| Cubist Systematic Strategies, LLC | $2.219.702 | 45.541 | 0,09% | Hisse senetleri |
| XTX Topco Ltd | $2.208.150 | 29.442 | 0,08% | Hisse senetleri |
| Legal & General Group Plc | $2.032.875 | 27.105 | 0,08% | Hisse senetleri |
| CARY STREET PARTNERS FINANCIAL LLC | $1.999.800 | 26.664 | 0,08% | Hisse senetleri |
| Nierenberg Investment Management Company, LLC | $1.971.000 | 26.280 | 0,08% | Hisse senetleri |
| Aurora Investment Counsel | $1.912.575 | 25.501 | 0,07% | Hisse senetleri |
| WESBANCO BANK INC | $1.912.500 | 25.500 | 0,07% | Hisse senetleri |
| Cardinal Capital Management | $1.861.275 | 24.817 | 0,07% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $1.846.275 | 24.617 | 0,07% | Hisse senetleri |
| Legato Capital Management LLC | $1.758.750 | 23.450 | 0,07% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.740.000 | 23.200 | 0,07% | Alım opsiyonu |
Şirket yöneticileri 72 içeriden öğrenenler · 48 yöneticiler · 25 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Christopher Simon, | President & CEO | 15 Mayıs 2026 A | 444.704 | 0 | 0 | $0 |
| Brian Concannon | President & CEO | 15 Eylül 2015 M | 147.040 | 0 | 0 | $0 |
| James Darecca | EVP, Chief Financial Officer | 15 Mayıs 2026 A | 54.444 | 0 | 0 | $0 |
| William P. Mr. Burke | EVP, Chief Financial Officer | 23 Ağustos 2021 M | 30.291 | 0 | 0 | $0 |
| Christopher J Lindop | CFO & EVP Business Development | 13 Ocak 2016 A | 56.743 | 0 | 0 | $0 |
| Ronald J Ryan | VP and CFO | 01 Kasım 2006 P | 2.101 | 0 | 0 | $0 |
| Stewart W Strong | President, Global Hospital | 26 Temmuz 2024 S | 18.196 | 0 | 0 | $0 |
| Byron Selman | President, Global Markets | 25 Ekim 2016 A | 23.318 | 0 | 0 | $0 |
| Peter M Allen | President, Global Plasma | 06 Temmuz 2015 M | 34.102 | 0 | 0 | $0 |
| Kelly Michael P | President, Global Markets | 11 Kasım 2013 M | 10.987 | 0 | 0 | $0 |
| Mikael Gordon | President, Global Markets | 03 Mayıs 2012 M | 4.442 | 0 | 0 | $0 |
| Remi Corlin | President, Asia | 08 Ağustos 2008 M | 884 | 0 | 0 | $0 |
| Keiko Hattori | President, Haemonetics Japan | 01 Mayıs 2008 P | 716 | 0 | 0 | $0 |
| Thomas Lawlor | President, Patient Division | 28 Kasım 2007 M | 0 | 0 | 0 | $0 |
| Ryoji Sakai | President, Japan | 14 Haziran 2007 M | 0 | 0 | 0 | $0 |
| Ulrich Eckert | President, Europe & Latin Am | 01 Kasım 2006 P | 890 | 0 | 0 | $0 |
| Yutaka Sakurada | President, Japan & Asia | 02 Mayıs 2005 P | 2.347 | 0 | 0 | $0 |
| Frank Chan | EVP, Chief Operating Officer | 15 Mayıs 2026 A | 32.936 | 0 | 0 | $0 |
| Kent J Davies | Chief Operating Officer | 23 Ekim 2015 S | 16.891 | 0 | 0 | $0 |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | 05 Haziran 2026 F | 6.242 | 0 | 0 | $0 |
| Laurie A. Miller | SVP, Human Resources | 05 Haziran 2026 F | 40.987 | 0 | 0 | $0 |
| Roy Galvin | EVP, Chief Commercial Officer | 15 Mayıs 2026 A | 39.882 | 0 | 0 | $0 |
| Michelle L Basil | EVP and General Counsel | 15 Mayıs 2026 A | 68.829 | 0 | 0 | $0 |
| Anila Lingamneni | EVP, Chief Technology Officer | 12 Temmuz 2024 S | 21.331 | 0 | 0 | $0 |
| Josep Llorens | EVP, Global Manufacturing | 28 Mayıs 2024 F | 30.940 | 0 | 0 | $0 |
| Dan Goldstein | VP, Corporate Controller | 13 Haziran 2022 S | 4.447 | 0 | 0 | $0 |
| Jacqueline Scanlan | SVP, Global Human Resources | 07 Haziran 2021 S | 4.216 | 0 | 0 | $0 |
| Said Bolorforosh | EVP, Chief Technology Officer | 11 Kasım 2019 S | 1.977 | 0 | 0 | $0 |
| Neil 122-62-507 Ryding | EVP, Global Manufacturing | 07 Haziran 2018 S | 15.226 | 0 | 0 | $0 |
| David Fusco | EVP, Global Human Resources | 25 Ekim 2016 A | 16.867 | 0 | 0 | $0 |
| Sandra Jesse | EVP and Chief Legal Officer | 25 Ekim 2016 A | 48.166 | 0 | 0 | $0 |
| Jonathan White | Chief Science and Technology | 26 Ekim 2015 S | 30.507 | 0 | 0 | $0 |
| Susan M Hanlon | VP Finance | 26 Ekim 2015 S | 20.464 | 0 | 0 | $0 |
| Brian R Burns | EVP, Global QA/RA | 23 Ekim 2015 S | 16.235 | 0 | 0 | $0 |
| Dave Helsel | EVP, Global Manufacturing | 13 Nisan 2015 D | 13.216 | 0 | 0 | $0 |
| Kathleen Mcdaniel | EVP Global Human Resources | 28 Ağustos 2014 S | 5.013 | 0 | 0 | $0 |
| Warren Nighan JR | EVP, Global QA/RA | 24 Temmuz 2013 A | 7.618 | 0 | 0 | $0 |
| Joseph J Forish | VP, Human Resources | 30 Nisan 2013 P | 17.279 | 0 | 0 | $0 |
| Phillip John Brancazio | VP, Global Manufacturing | 04 Mayıs 2011 P | 3.052 | 0 | 0 | $0 |
| Alicia R Lopez | VP, Corporate Affairs | 05 Nisan 2011 D | 2.815 | 0 | 0 | $0 |
| Michael I Ruxin | VP Global Software Strategies | 04 Kasım 2010 P | 215 | 0 | 0 | $0 |
| Brad Nutter | Chairman of the Board | 29 Temmuz 2010 A | 10.580 | 0 | 0 | $0 |
| Robert B Ebbeling | Vice President, Operations | 01 Mayıs 2009 P | 15.849 | 0 | 0 | $0 |
| Jan Conneely | VP & GM, Arryx, Inc. | 01 Mayıs 2008 P | 1.041 | 0 | 0 | $0 |
| William Granville | VP, Manufacturing | 01 Mayıs 2008 P | 12.188 | 0 | 0 | $0 |
| Mark A Popovsky | VP, Corporate Medical Director | 01 Mayıs 2008 P | 4.891 | 0 | 0 | $0 |
| Stephen Swenson | VP & General Mgr, Global Plasm | 01 Mayıs 2008 P | 3.024 | 0 | 0 | $0 |
| William Roche Still | VP & Gen Mrg, Therapeutics Bus | 04 Mayıs 2007 M | 4.193 | 0 | 0 | $0 |
| Lloyd Emerson Johnson | Yönetim kurulu üyesi | 24 Temmuz 2026 A | 15.471 | 0 | 0 | $0 |
| Diane M Bryant | Yönetim kurulu üyesi | 24 Temmuz 2026 A | 9.664 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 8 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 06 Şubat 2004 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 20 Ağustos 2003 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 08 Ağustos 2003 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 24 Haziran 2003 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 19 Haziran 2003 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 03 Haziran 2003 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 27 Mayıs 2003 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 15 Haziran 2001 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 88 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| NBSM · Neuberger Berman ETF Trust | 1,86% | 61.981 NS | 31 Mayıs 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,84% | 43.927 NS | 30 Nisan 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,77% | 125.093 NS | 30 Nisan 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,64% | 5.836 NS | 30 Nisan 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,46% | 12.701 NS | 31 Mayıs 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,36% | 110.180 NS | 30 Haziran 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,35% | 201.070 NS | 30 Nisan 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,32% | 35.814 NS | 31 Mayıs 2026 | N-PORT |
| ABCS · EA Series Trust | 0,31% | 522 NS | 29 Mayıs 2026 | N-PORT |
| IWO · iShares Trust | 0,29% | 411.897 SH | 20 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,29% | 75.696 SH | 20 Ağustos 2026 | Günlük |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,24% | 41.437 NS | 30 Nisan 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,20% | 47.624 SH | 19 Ağustos 2026 | Günlük |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,19% | 76.694 NS | 31 Mayıs 2026 | N-PORT |
| IWM · iShares Trust | 0,16% | 1.212.781 SH | 20 Ağustos 2026 | Günlük |
| PKW · Invesco Exchange-Traded Fund Trust | 0,15% | 24.474 SH | 20 Ağustos 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 17.393 NS | 30 Nisan 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,13% | 5.332 SH | 20 Ağustos 2026 | Günlük |
| MIDE · DBX ETF Trust | 0,13% | 63 NS | 29 Mayıs 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,13% | 1.703 NS | 30 Nisan 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 12.097 NS | 30 Nisan 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,12% | 2.419 NS | 30 Nisan 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,11% | 27.512 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 271.486 SH | 19 Ağustos 2026 | Günlük |
| NUSC · Nushares ETF Trust | 0,11% | 23.551 NS | 30 Nisan 2026 | N-PORT |
| ESML · iShares Trust | 0,11% | 29.513 SH | 20 Ağustos 2026 | Günlük |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 42.163 NS | 30 Nisan 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,10% | 74.976 SH | 19 Ağustos 2026 | Günlük |
| FNDA · SCHWAB STRATEGIC TRUST | 0,10% | 126.817 NS | 31 Mayıs 2026 | N-PORT |
| ISCV · iShares Trust | 0,09% | 6.131 SH | 20 Ağustos 2026 | Günlük |
| EBIT · Harbor ETF Trust | 0,09% | 168 NS | 30 Nisan 2026 | N-PORT |
| RSSL · Global X Funds | 0,09% | 20.324 NS | 30 Nisan 2026 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,08% | 15.968 SH | 19 Ağustos 2026 | Günlük |
| ITWO · ProShares Trust | 0,08% | 2.210 NS | 31 Mayıs 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,08% | 5.212 NS | 30 Nisan 2026 | N-PORT |
| ISCB · iShares Trust | 0,07% | 2.011 SH | 20 Ağustos 2026 | Günlük |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,07% | 9.144 SH | 20 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,07% | 159.737 NS | 30 Nisan 2026 | N-PORT |
| MVV · ProShares Trust | 0,07% | 1.606 NS | 31 Mayıs 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,07% | 222.776 NS | 31 Mayıs 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,06% | 12.283 NS | 30 Nisan 2026 | N-PORT |
| ISCG · iShares Trust | 0,06% | 5.390 SH | 20 Ağustos 2026 | Günlük |
| MIDU · Direxion Shares ETF Trust | 0,06% | 770 NS | 30 Nisan 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,05% | 2.220 NS | 31 Mayıs 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,05% | 1.979 NS | 31 Mayıs 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 302.003 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,05% | 139.826 SH | 19 Ağustos 2026 | Günlük |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,05% | 3.866 NS | 30 Nisan 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 3.008 SH | 20 Ağustos 2026 | Günlük |
| UMDD · ProShares Trust | 0,05% | 224 NS | 31 Mayıs 2026 | N-PORT |